Oversonic Robotics, an Italian company specializing in cognitive humanoid robotics, has agreed a strategic partnership in the United States with NantWorks, alongside the opening of a new Los Angeles office.
The announcement was made during the inaugural US-Saudi Biotech Alliance Summit, held in conjunction with the 44th Annual JPMorgan Healthcare Conference in San Francisco.
This agreement marks an important step in the company’s international expansion. The collaboration brings together Oversonic’s technological excellence with NantWorks unique expertise in the medical and aerospace sectors, strengthening the company’s ability to develop advanced cognitive robotic solutions for industrial and healthcare applications.
The partnership with NantWorks will allow Oversonic to accelerate research and development in both medical and aerospace sectors, consolidating the integration of cognitive robotics, artificial intelligence, and automation in real-world environments.
In the medical field, the collaboration focuses on developing safe and reliable robotic platforms for hospitals and healthcare facilities, and thanks to the partnership, Oversonic’s first cognitive humanoid robots will be brought into US clinics in the coming months to begin clinical trials and test the machines in interaction with patients.
In the aerospace sector, the aim is to apply Oversonic’s technological platforms for space environments, enabling advanced robotic solutions for exploration and infrastructure support, with a primary focus on lunar missions.
The initial target includes projects related to lunar exploration and infrastructure development, particularly in support of future activities in the lunar South Pole area and the Lunar Gateway, the new orbiting space station.
The agreement also reinforces Oversonic’s presence in the US market, with the opening of a new Los Angeles office of 5,000 square feet in Mariposa Avenue (El Segundo, California).
The facility will serve as a hub for the technological development of medical machines, as well as for coordinating expansion across the country, following a strategic approach based on technological alliances and industrial coalitions.
Fabio Puglia, chairman of Oversonic, says: “This partnership represents a decisive step in our international growth strategy and confirms our vision to transform cognitive robotics into concrete, innovative solutions that generate real value in the industrial and medical sectors.
“This technological alliance with Dr Patrick Soon-Shiong is also based the joint development and shared use of highly advanced proprietary intellectual property.
“By combining Oversonic’s platforms with disruptive IP already developed and made available through this collaboration, we will accelerate innovation and bring new high-technology capabilities to market in the coming months.”
Paolo Denti, CEO of Oversonic, says: “Oversonic’s participation in the Inaugural US-Saudi Biotech Alliance Summit marks, from the very beginning of the year, the second key milestone in our growth journey in the United States after CES in Vegas.
“Being part of high-level international forums like this reinforces our global positioning and demonstrates our commitment to shaping the future of robotics and artificial intelligence in healthcare.
“This partnership opens American market opportunities, with the brand new office in Los Angeles. Within a few months, we will be able to bring the first humanoids into US clinics, where we will start clinical trials and test the machines directly in interaction with patients.”
